Greg Sherman is an experienced attorney with a diverse legal background. They served as an Associate Attorney at Sidley Austin LLP from 2012 to 2016, and later held multiple roles at Gilead Sciences, culminating in their position as Sr. Associate General Counsel and Head of U.S. HIV Therapeutic Area in 2022. Prior to Gilead, Greg worked as an Associate Attorney at Hooper, Lundy & Bookman and was the Legislative Director at Beacon Consulting Group from 2001 to 2004. Throughout their career, they have demonstrated leadership in supporting global commercial strategies and various therapeutic areas.
This person is not in the org chart
This person is not in any teams
This person is not in any offices